Related Experiment Videos
[Left ventricular hypertrophy of the hypertensive patient. Approach to its pathogenesis and consequences]
Insights
Left ventricular hypertrophy (LVH) in hypertension is increasingly monitored using echocardiography as a marker of disease severity and treatment effectiveness. While LVH regression is beneficial, its role as a primary treatment goal requires further prognostic study.
Area of Science:
- Cardiology
- Hypertension Research
- Diagnostic Imaging
Context:
- Left ventricular hypertrophy (LVH) is a significant concern in patients with hypertension.
- Echocardiography has advanced the understanding of LVH characteristics and consequences.
- LVH is increasingly utilized as an index of hypertension severity and a measure of treatment efficacy.
Purpose:
- To summarize the current understanding of left ventricular hypertrophy (LVH) in hypertensive patients.
- To highlight the role of echocardiography in assessing LVH.
- To discuss the implications of LVH regression in hypertension management.
Summary:
- Echocardiography provides reliable measurements of left ventricular mass, aiding in hypertension severity assessment and treatment evaluation.
- Despite advances, the precise pathogenesis of LVH in hypertension remains incompletely understood, with factors beyond afterload influencing its development.
- Evidence suggests that regression of LVH is beneficial for hypertensive patients, though its definitive role in anti-hypertensive treatment strategies needs validation through prognostic studies.
Impact:
- Improved diagnostic capabilities for hypertension severity through echocardiography.
- Enhanced understanding of LVH pathogenesis in hypertensive individuals.
- Informing future clinical guidelines on managing LVH and hypertension.
- Guiding the development of targeted anti-hypertensive therapies.
Abstract:
The knowledge of the characteristics and consequences of left ventricular hypertrophy (LVH) in the hypertensive patient has greatly progressed in the past few years, owing to echocardiography. This examination provides a reliable and reproducible measurement, and therefore the left ventricular mass is used more and more as a severity index of hypertension and a mean of evaluation of the efficacy of the treatment. This attitude is justified in part by the poor prognosis of LVH. However, the pathogenesis of LVH in hypertension still presents numerous unknown facts. If the elevation of the post-charge seems to be the essential mechanism, other factors seem to have an important influence and explain the uneven effect of different hypertensive drugs at this level. Presently, there are several arguments in favor of the beneficial character of the regression of LVH in the hypertensive patient under treatment, but we will have to wait for the result of prognostic studies to use this property as a major objective of anti-hypertensive treatments.